Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Status:
Completed
Trial end date:
2018-10-15
Target enrollment:
Participant gender:
Summary
The study evaluates safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of
emodepside, after administration as a Liquid Service Formulation (LSF), over 10 days, in
healthy male caucasian subjects.